Lose the weight with a physician-led GLP-1 program
This comprehensive guide can tell you better about which weight loss medication you should choose
What the Clinical Trials Tell Us The most important direct comparison is the SURMOUNT-5 trial (NEJM 2025), which compared tirzepatide and semaglutide head-to-head in adults with obesity (without type 2 diabetes)
OZEMPIC- oral semaglutide tablet RYBELSUS- oral semaglutide tablet Novo Nordisk Pharmaceutical Industries, LP ---------- RYBELSUS and OZEMPIC tablets are indicated: RYBELSUS: Recommended Dosage Follow the RYBELSUS starting, escalation, and maintenance dosage described below to reduce the risk of gastrointestinal (GI) adverse reactions [see Warnings and Precautions (5.6), Adverse Reactions (6.1)]: OZEMPIC Tablets: Recommended Dosage Follow the OZEMPIC tablets starting, escalation, and maintenance dosage described below to reduce the risk of GI adverse reactions [see Warnings and Precautions (5.6), Adverse Reactions (6.1)]: Table 1
Rohini Shantharam is a board-certified dermatologist in Fresno, CA Dr
If you wish to discontinue therapy with our hormonally active substances, you should not do so abruptly, but should reduce the dosage gradually over a period of 4 to 5 weeks in consultation with your doctor
